Obstructive airway diseases including asthma, chronic obstructive pulmonary disease and cystic fibrosis present with dyspnea and variety of other symptoms. Physiologically, they are characterized by maximal expiratory flow limitation and pathologically, by inflammation of the airways and the lung parenchyma. Inflammation plays a major role in the gradual worsening of the lung function resulting in worsening symptoms. For many years, scientists focused their efforts in identifying various pathways involved in the chronic inflammation present in these diseases. Further, studies are underway to identify various molecular targets in these pathways for the purpose of developing novel therapeutic agents. Natural agents have been used for thousands of years in various cultures for the treatment of several medical conditions and have mostly proven to be safe. Recent in vivo and in vitro studies show potential anti-inflammatory role for some of the existing natural agents. This review provides an overview of the literature related to the anti-inflammatory effects of some of the natural agents which have potential value in the treatment of inflammatory lung diseases.
Picrorhiza kurroa.Monograph. ( 2001) Altern Med Rev6: 319—321.
2.
Aihara, M. et al. (2000) Effects of N-acetylcysteine and ambroxol on the production of IL-12 and IL-10 in human alveolar macrophages. Respiration67: 662—671.
3.
Ali, M. and Bhutani, K.K. (1989) Investigation of Medicinal-Plants 11. Alkaloids from Tylophora-Indica. Phytochemistry28: 3513—3517.
4.
Aoshiba, K. (2007) Role of alveolar cell apoptosis in COPD. Nippon Rinsho65: 629—632.
5.
Armstrong, M.L. (1976) Double-blind crossover trial of bromhexine (Bisolvon) in the treatment of chronic bronchitis. Med J Aust1: 612,614—5,617.
6.
Babcock, T.A. et al. (2003) Inhibition of activator protein-1 transcription factor activation by omega-3 fatty acid modulation of mitogen-activated protein kinase signaling kinases. JPEN J Parenter Enteral Nutr27: 176—180.
7.
Barnes, P.J. (2004) New drugs for asthma. Nat Rev Drug Discov3: 831—844.
8.
Barnes, P.J. et al. (2005) Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur Respir J25: 552—563.
9.
Barnes, P.J. and Hansel, T.T. (2004) Prospects for new drugs for chronic obstructive pulmonary disease. Lancet364: 985—996.
10.
Bianchini, F. and Vainio, H. (2003) Wine and resveratrol: mechanisms of cancer prevention?Eur J Cancer Prev12: 417—425.
11.
Bines, J.E. et al. (2005) Vitamin A and E deficiency and lung disease in infants with cystic fibrosis. J Paediatr Child Health41: 663—668.
12.
Birrell, M.A. et al. (2005) Resveratrol, an extract of red wine, inhibits lipopolysaccharide induced airway neutrophilia and inflammatory mediators through an NF-kappaB-independent mechanism. FASEB J19: 840—841.
13.
Brouet, I. and Ohshima, H. (1995) Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages . Biochem Biophys Res Commun206: 533—540.
14.
Bunnett, N.W. (2006) Protease-activated receptors: how proteases signal to cells to cause inflammation and pain. Semin Thromb Hemost32(Suppl 1): 39—48.
15.
Cambridge, G.W., Jansen, A.B., and Jarman, D.A. (1962) Bronchodilating action of vasicinone and related compounds. Nature196: 1217.
16.
Celotti, E. et al. (1996) Resveratrol content of some wines obtained from dried Valpolicella grapes: Recioto and Amarone. J Chromatogr A 730: 47—52.
17.
Chan, M.M. et al. (1998) In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. Biochem Pharmacol55: 1955—1962.
18.
Chemexil. (1992) Adhatoda vasica in selected medicinal plants of India. Chemexil15—18. India.
19.
Cho, D.I. et al. (2002) Effects of resveratrol-related hydroxystilbenes on the nitric oxide production in macrophage cells: structural requirements and mechanism of action. Life Sci71: 2071—2082.
20.
Claeson, U.P. et al. (2000) Adhatoda vasica: a critical review of ethnopharmacological and toxicological data. J Ethnopharmacol72: 1—20.
21.
Csiszar, A. et al. (2006) Resveratrol attenuates TNF-alpha-induced activation of coronary arterial endothelial cells: role of NF-kappaB inhibition . Am J Physiol Heart Circ Physiol291: H1694—H1699.
22.
Culpitt, S.V. et al. (2003) Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD. Thorax58: 942—946.
23.
Demedts, I.K. et al. (2006) Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res7: 53.
24.
Donnelly, L.E. et al. (2004) Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. Am J Physiol Lung Cell Mol Physiol287: L774—L783.
25.
Dorsch, W. et al. (1991) Antiasthmatic effects of Picrorhiza kurroa: androsin prevents allergen- and PAF-induced bronchial obstruction in guinea pigs. Int Arch Allergy Appl Immunol95: 128—133.
26.
Fira-Mladinescu, O. et al. (2007) New concepts in the pathogenesis and pathophysiology of COPD. Pneumologia56: 24, 26—24, 31.
27.
Fremont, L. (2000) Biological effects of resveratrol. Life Sci66: 663—673.
28.
Ganguly, T., Badheka, L.P. and Sainis, K.B. (2001) Immunomodulatory effect of Tylophora indica on Con A induced lymphoproliferation. Phytomedicine8: 431—437.
29.
Ganguly, T. and Sainis, K.B. (2001) Inhibition of cellular immune responses by Tylophora indica in experimental models. Phytomedicine8: 348—355.
30.
Gibbs, B.F. et al. (1999) Ambroxol inhibits the release of histamine, leukotrienes and cytokines from human leukocytes and mast cells. Inflamm Res48: 86—93.
31.
Gopalakrishnan, C. et al. (1979) Pharmacological investigations of tylophorine, the major alkaloid of Tylophora indica. Indian J Med Res69: 513—520.
32.
Gore, K.V., Rao, A.K., and Guruswamy, M.N. (1980) Physiological studies with Tylophora asthmatica in bronchial asthma. Indian J Med Res71: 144—148.
33.
Grange, J.M. and Snell, N.J. (1996) Activity of bromhexine and ambroxol, semi-synthetic derivatives of vasicine from the Indian shrub Adhatoda vasica, against Mycobacterium tuberculosis in vitro. J Ethnopharmacol50: 49—53.
34.
Gupta, O.P. and et al. (1977) Pharmacological investigations of vasicine and vasicinone-the alkaloids of Adhatoda vasica. Indian J Med Res66: 690—691.
35.
Hogg, J.C. et al. (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med350: 2645—2653.
36.
Holmes-McNary, M. and Baldwin, A.S., Jr. (2000) Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase. Cancer Res60: 3477—3483.
37.
Hong, J. et al. (2004) Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase. Carcinogenesis25: 1671—1679.
38.
Hu, G. and Cassano, P.A. (2000) Antioxidant nutrients and pulmonary function: the Third National Health and Nutrition Examination Survey (NHANES III). Am J Epidemiol151: 975—981.
39.
Johnson, D.K. et al. (2002) Inhibition of NADPH oxidase activation in endothelial cells by ortho-methoxy-substituted catechols. Endothelium9: 191—203.
40.
Juan, M.E. et al. (1999) Determination of trans-resveratrol in plasma by HPLC. Anal Chem71: 747—750.
41.
Kang, O.H. et al. (2005) Inhibition of interleukin-8 production in the human colonic epithelial cell line HT-29 by 18 beta-glycyrrhetinic acid . Int J Mol Med15: 981—985.
42.
Karin, M. (1995) The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem270: 16483—16486.
43.
Kim,Y.A. et al. (2003) Involvement of p21WAF1/CIP1, pRB, Bax and NF-kappaB in induction of growth arrest and apoptosis by resveratrol in human lung carcinoma A549 cells. Int J Oncol23: 1143—1149.
44.
Kumar, A. et al. (2005) Modulatory influence of Adhatoda vasica Nees leaf extract against gamma irradiation in Swiss albino mice. Phytomedicine12: 285—293.
45.
Kurup, V.P. et al. (2007) Immune response modulation by curcumin in a latex allergy model. Clin MolAllergy5: 1.
46.
Kutkin (2001) Picrorhiza kurroa Monograph. Alternative Medicine Review2001. 6(3): 319—321.
47.
Lal, S. and Bhalla, K.K. (1975) A controlled trial of bromhexine (`Bisolvon') in out-patients with chronic bronchitis. Curr Med Res Opin3: 63—67.
48.
LeBlanc, M. (2006) Cultivar, juice extraction, ultra violet irradiation and storage influence the stilbene content of muscadine grape (Vitis rotundifolia Michx.). Louisiana State University and Agricultural and Mechanical College.
49.
Lee, E.O. et al. (2006) Potent inhibition of Lewis lung cancer growth by heyneanol A from the roots of Vitis amurensis through apoptotic and anti-angiogenic activities. Carcinogenesis27: 2059—2069.
50.
Leiro, J. et al. (2004) Effects of cis-resveratrol on inflammatory murine macrophages: antioxidant activity and down-regulation of inflammatory genes. J Leukoc Biol75: 1156—1165.
51.
Lin, J.K. (2007) Molecular targets of curcumin. Adv Exp Med Biol595: 227—243.
52.
Lu, M. et al. (2002) Efficiency and structure-activity relationship of the antioxidant action of resveratrol and its analogs. Pharmazie57: 474—478.
53.
Ma, Z.H. et al. (2005) Effect of resveratrol on peritoneal macrophages in rats with severe acute pancreatitis. Inflamm Res54: 522—527.
Mahajani, S.S. and Kulkarni, R.D. (1977) Effect of disodium cromoglycate and Picrorhiza kurroa root powder on sensitivity of guinea pigs to histamine and sympathomimetic amines. Int Arch Allergy Appl Immunol53: 137—144.
56.
Manna, S.K. et al. (2000) Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol164: 6509—6519.
57.
Martin, A.R. et al. (2006) The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model. Br J Pharmacol147: 873—885.
58.
Menon, V.P. and Sudheer, A.R. (2007) Antioxidant and anti-inflammatory properties of curcumin. Adv Exp Med Biol595: 105—125.
59.
Mokni, M. et al. (2007) Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat. Neurochem Res32: 981—987.
60.
Murcia, M.A. and Martinez-Tome, M. (2001) Antioxidant activity of resveratrol compared with common food additives. J Food Prot64: 379—384.
61.
Muro, S. (2007) Airway inflammation in COPD. Nippon Rinsho65: 644—647.
62.
Nam, N.H. (2006) Naturally occurring NF-kappaB inhibitors. Mini Rev Med Chem6: 945—951.
63.
Olas, B. and Wachowicz, B. (2005) Resveratrol, a phenolic antioxidant with effects on blood platelet functions. Platelets16: 251—260.
64.
Olas, B. et al. (2001) Antioxidant activity of resveratrol in endotoxin-stimulated blood platelets. Cell Biol Toxicol17: 117—125.
65.
Orallo, F. (2006) Comparative studies of the antioxidant effects of cis- and trans-resveratrol. Curr Med Chem13: 87—98.
66.
Paliwa, J.K. et al. (2000) Pharmacokinetics and in-situ absorption studies of a new anti-allergic compound 73/602 in rats. Int J Pharm197: 213—220.
67.
Pan, M.H. et al. (2007) Pterostilbene induces apoptosis and cell cycle arrest in human gastric carcinoma cells. J Agric Food Chem55: 7777—7785.
68.
Peters, E.A. et al. (2001) Effect of apocynin on ozone-induced airway hyperresponsiveness to methacholine in asthmatics. Free Radic Biol Med31: 1442—1447.
69.
Rahman, I. and Adcock, I.M. (2006) Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J28: 219—242.
70.
Rahman, I. et al. (2006) Regulation of inflammation and redox signaling by dietary polyphenols. Biochem Pharmacol72: 1439—1452.
71.
Ray, A.L. et al. (2006) Low serum selenium and total carotenoids predict mortality among older women living in the community: the women's health and aging studies. J Nutr136: 172—176.
72.
Reed, C.E. and Kita, H. (2004) The role of protease activation of inflammation in allergic respiratory diseases. J Allergy Clin Immunol114: 997—1008.
73.
Renaud, S. and de Lorgeril, M. (1992) Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet339: 1523—1526.
74.
Renaud, S. and Gueguen, R. (1998) The French paradox and wine drinking. Novartis Found Symp216: 208—217.
75.
Renaud, S. and Ruf, J.C. (1994) The French paradox: vegetables or wine. Circulation90: 3118—3119.
76.
Riccioni, G. et al. (2007) Plasma lycopene and antioxidant vitamins in asthma: the PLAVA study. J Asthma44: 429—432.
77.
Richard, N. et al. (2005) Effects of resveratrol, piceatannol, tri-acetoxystilbene, and genistein on the inflammatory response of human peripheral blood leukocytes. Mol NutrFood Res49: 431—442.
78.
Romieu, I. and Trenga, C. (2001) Diet and obstructive lung diseases. Epidemiol Rev23: 268—287.
79.
Saetta, M.A.R.I. (1999) Airway inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med160: 17S—20.
80.
Schouten, A. et al. (2002) Resveratrol acts as a natural profungicide and induces self-intoxication by a specific laccase. Mol Microbiol43: 883—894.
81.
Shankar, S. et al. (2007) Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential. Front Biosci12: 4839—4854.
82.
Sharma, S. et al. (2007) Resveratrol and curcumin suppress immune response through CD28/CTLA-4 and CD80 co-stimulatory pathway. Clin Exp Immunol147: 155—163.
83.
Shen, F. et al. (2003) Suppression of IL-8 gene transcription by resveratrol in phorbol ester treated human monocytic cells. J Asian Nat Prod Res5: 151—157.
84.
Stetinova, V. et al. (2004) In vitro and in vivo antioxidant activity of ambroxol. Clin Exp Med4: 152—158.
85.
Stojanovic, S. et al. (2001) Efficiency and mechanism of the antioxidant action of trans-resveratrol and its analogues in the radical liposome oxidation . Arch Biochem Biophys391: 79—89.
86.
Stolk, J. et al. (1994) Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol . Am J Respir Cell Mol Biol11: 95—102.
87.
Stolk, J. et al. (1994) Apocynin improves the efficacy of secretory leukocyte protease inhibitor in experimental emphysema. Am J Respir Crit Care Med150: 1628—1631.
88.
Su, X. et al. (2004) Inhibition of inflammatory responses by ambroxol, a mucolytic agent, in a murine model of acute lung injury induced by lipopolysaccharide. Intensive Care Med30: 133—140.
89.
Surh,Y.J. et al. (2001) Molecular mechanisms underlying chemopreventive activities of antiinflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res480—481: 243—268.
90.
Takahashi, M. et al. (2007) Curcumin (1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) blocks the chemotaxis of neutrophils by inhibiting signal transduction through IL-8 receptors. Mediators Inflamm2007: 10767.
91.
Thabut, G. et al. (2002) Tumor necrosis factor-alpha increases airway smooth muscle oxidants production through a NADPH oxidase-like system to enhance myosin light chain phosphorylation and contractility. J Biol Chem277: 22814—22821.
92.
Tuder, R.M. et al. (2006) State of the art. Cellular and molecular mechanisms of alveolar destruction in emphysema: an evolutionary perspective . Proc Am Thorac Soc3: 503—510.
93.
Udupa, A.L., Udupa, S.L. and Guruswamy, M.N. (1991) The possible site of anti-asthmatic action of Tylophora asthmatica on pituitary-adrenal axis in albino rats. Planta Med57: 409—413.
94.
Valenti, S. and Marenco, G. (1989) Italian multi-center study on the treatment of chronic obstructive lung disease with bromhexine. A double-blind placebo-controlled trial. Respiration56: 11—15.
95.
Van den, W.E. et al. (2001) Effects of methoxylation of apocynin and analogs on the inhibition of reactive oxygen species production by stimulated human neutrophils. Eur J Pharmacol433: 225—230.
96.
Varraso, R. et al. (2007a) Prospective study of dietary patterns and chronic obstructive pulmonary disease among US women. Am J Clin Nutr86: 488—495.
97.
Varraso, R. et al. (2007b) Prospective study of dietary patterns and chronic obstructive pulmonary disease among US men. Thorax62: 786—791.
98.
Wenzel, E. and Somoza, V. (2005) Metabolism and bioavailability of trans-resveratrol. Mol NutrFood Res49: 472—481.
99.
Wiessmann, K.J. and Niemeyer, K. (1978) Clinical results in the treatment of chronic obstructive bronchitis with ambroxol in comparison with bromhexine (author's transl). Arzneimittelforschung28: 918—921.
100.
Wood, L.G., Fitzgerald, D.A. and Garg, M.L. (2003) Hypothesis: vitamin E complements polyunsaturated fatty acids in essential fatty acid deficiency in cystic fibrosis. J Am Coll Nutr22: 253—257.
101.
Wung, B.S. et al. (2005) Resveratrol suppresses IL-6-induced ICAM-1 gene expression in endothelial cells: effects on the inhibition of STAT3 phosphorylation . Life Sci78: 389—397.
102.
Yang, C.W. et al. (2006) Anti-inflammatory mechanisms of phenanthroindolizidine alkaloids. MolecularPharmacology69: 749—758.
103.
Zhang,Y. et al. (2004) Novel lipid-peroxidation- and cyclooxygenase-inhibitory tannins from Picrorhiza kurroa seeds. Chem Biodivers1: 426—441.
104.
Zhang,Y. et al. (2005) Cyclooxygenase-2 enzyme inhibitory triterpenoids from Picrorhiza kurroa seeds. Life Sci77: 3222—3230.
105.
Zunino, S.J. and Storms, D.H. (2006) Resveratrol-induced apoptosis is enhanced in acute lymphoblastic leukemia cells by modulation of the mitochondrial permeability transition pore. Cancer Lett240: 123—134.
